|
||||||||
National Center for Chronic Disease Prevention and Health Promotion Arthritis Home | About Us | Contact Us |
|
|
ICD-9-CM Code and Condition ‡ | Percent of Prevalence | Percent of Visits † | |
---|---|---|---|
727.0 | Synovitis and tenosynovitis | 31.3 | 23.2 |
729.1 | Myalgia and myositis, unspecified | 22.9 | 26.9 |
715 | Osteoarthrosis and allied disorders | 10.9 | 6.7 |
710 | Diffuse diseases of connective tissue | 7.2 | 6.4 |
714 | Rheumatoid arthritis and other inflammatory polyarthropathies | 5.4 | 7.4 |
287.0 | Allergic purpura | 5.3 | 6.9 |
711 | Arthropathy associated with infections | 5.2 | 6.9 |
716 | Other and unspecified arthropathies | 3.0 | 3.0 |
446 | Polyarteritis nodosa and allied conditions | 2.4 | 3.4 |
Remaining SPARC Codes§ | 6.4 | 9.2 |
* ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; SPARC = significant pediatric arthritis and other rheumatologic conditions.
† Visit data include 83,000 emergency department visits that were not used to estimate prevalence.
‡ Estimates for 727.0, 729.1, 710, and 714 are based on samples of 42–104 records, but relative standard errors exceed 30%. All the remaining code estimates are based on <30 records.
§ Data not shown individually for codes with estimated proportions below 3% for prevalence or visits. Such codes include 099.3 Reactive arthritis; 136.1 Behcet's syndrome; 274 Gout; 277.3 Amyloidosis; 390–391 Rheumatic fever; 437.4 Cerebral arteritis; 443.0 Raynaud’s syndrome; 447.6 Arteritis, unspecified; 695.2 Erythema nodosum; 696.0 Psoriatic arthropathy; 701.0 Circumscribed scleroderma; 712 Crystal arthropathies; 713 Arthropathy associated with other disorders classified elsewhere; 719.2 Villonodular synovitis; 719.3 Palindromic rheumatism; 720 Ankylosing spondylitis and other inflammatory spondylopathies; and 729.0 Rheumatism, unspecified and fibrositis.
Reference
Sacks JJ, Helmick CG, Luo YH, Ilowite NT, Bowyer S. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001–2004. Arthritis Care Res 2007;57(8):1439–1445. abstract
Children <18 yrs old |
ICD-9-CM-
based estimates |
|
---|---|---|
United States | 72,969,000 | 294,000 (188,000–400,000) |
Alabama | 1,107,500 | 4,500 (2,900–6,000) |
Alaska | 190,900 | 800 (500–1,000) |
Arizona | 1,498,100 | 6,000 (3,900–8,200) |
Arkansas | 679,800 | 2,700 (1,700–3,700) |
California | 9,436,200 | 38,000 (24,300–51,700) |
Colorado | 1,151,900 | 4,600 (3,000–6,300) |
Connecticut | 854,100 | 3,400 (2,200–4,700) |
Delaware | 194,300 | 800 (500–1,000) |
Dist. of Columbia | 110,300 | 400 (300–600) |
Florida | 3,903,200 | 15,800 (10,000–21,400) |
Georgia | 2,282,600 | 9,200 (5,900–12,500) |
Hawaii | 296,300 | 1,200 (800–1,600) |
Idaho | 371,200 | 1,500 (1,000–2,000) |
Illinois | 3,254,600 | 13,100 (8,300–17,800) |
Indiana | 1,599,400 | 6,400 (4,100–8,800) |
Iowa | 695,700 | 2,800 (1,800–3,800) |
Kansas | 695,800 | 2,800 (1,800–3,800) |
Kentucky | 962,900 | 3,900 (2,500–5,300) |
Louisiana | 1,181,600 | 4,800 (3,000–6,500) |
Maine | 282,900 | 1,100 (700–1,600) |
Maryland | 1,379,000 | 5,600 (3,500–7,600) |
Massachusetts | 1,475,200 | 5,900 (3,800–8,100) |
Michigan | 2,554,600 | 10,300 (6,600–14,000) |
Minnesota | 1,250,400 | 5,000 (3,200–6,900) |
Mississippi | 761,000 | 3,100 (2,000–4,200) |
Missouri | 1,402,400 | 5,700 (3,600–7,700) |
Montana | 216,100 | 900 (600–1,200) |
Nebraska | 440,100 | 1,800 (1,100–2,400) |
Nevada | 577,000 | 2,300 (1,500–3,200) |
New Hampshire | 308,300 | 1,200 (800–1,700) |
New Jersey | 2,129,500 | 8,600 (5,500–11,700) |
New Mexico | 501,300 | 2,000 (1,300–2,700) |
New York | 4,573,000 | 18,400 (11,800–25,100) |
North Carolina | 2,078,100 | 8,400 (5,300–11,400) |
North Dakota | 146,800 | 600 (400–800) |
Ohio | 2,847,600 | 11,500 (7,300–15,600) |
Oklahoma | 875,900 | 3,500 (2,300–4,800) |
Oregon | 852,100 | 3,400 (2,200–4,700) |
Pennsylvania | 2,847,100 | 11,500 (7,300–15,600) |
Rhode Island | 241,600 | 1,000 (600–1,300) |
South Carolina | 1,001,300 | 4,000 (2,600–5,500) |
South Dakota | 195,500 | 800 (500–1,100) |
Tennessee | 1,399,600 | 5,600 (3,600–7,700) |
Texas | 6,171,200 | 24,900 (15,900–33,800) |
Utah | 728,000 | 2,900 (1,900–4,000) |
Vermont | 138,600 | 600 (400–800) |
Virginia | 1,789,100 | 7,200 (4,600–9,800) |
Washington | 1,505,000 | 6,100 (3,900–8,300) |
West Virginia | 390,000 | 1,600 (1,000–2,100) |
Wisconsin | 1,335,500 | 5,400 (3,400–7,300) |
Wyoming | 121,700 | 500 (300–700) |
* Estimates based on dividing national ICD-9-CM-based any diagnosis SPARC prevalence by the child population younger than 18 years of age and applying that rate to state-specific populations. All estimates rounded to the nearest 100.
† ICD-9-CM = International Classification of Diseases, Ninth Revision, Clinical Modification; CI = confidence interval.
Reference
Sacks JJ, Helmick CG, Luo YH, Ilowite NT, Bowyer S. Prevalence of and annual ambulatory health care visits for pediatric arthritis and other rheumatologic conditions in the United States in 2001–2004. Arthritis Care Res 2007;57(8):1439–1445. abstract
Page last review: June 8, 2008
Page last modified: December 6, 2007
Content Source:
Division of
Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion
Privacy
Policy | Accessibility United
States Department of Health and Human Services |